Võrdle meetodeid

	Tableti küsimustik ravimitele allumise hindamiseks	Medication Adherence Rating Scale (MARS)
Valdkond	Farmakoloogia	Farmakoloogia
Perekond	Process / pipeline	Process / pipeline
Tekkeaasta	2012	2000
Looja	Adeniji and Brown	Kathryn Thompson, Jayashri Kulkarni, and Anthony A. Sergejew
Tüüp	Self-report	Self-report
Algallikas	Adeniji, B., & Brown, C. (2012). Tablet Questionnaire: A simple tool to assess medication non-adherence. Annals of African Medicine, 11(4), 202-205.	Thompson, K., Kulkarni, J., & Sergejew, A. A. (2000). Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophrenia Research, 42(3), 241-247.
Rööpnimetused	Tablet Questionnaire, TAB-Q	MARS
Seotud	4	4
Kokkuvõte	The Tablet Questionnaire is a brief, simple self-report tool designed to assess medication non-adherence through direct questions about dose-skipping behavior and reasons for non-adherence. Developed by Adeniji and Brown in 2012, it prioritizes simplicity and cultural accessibility, making it particularly valuable in low-resource settings and populations with limited health literacy. Despite its brevity, the measure demonstrates good sensitivity for detecting non-adherence and has been validated across African and international populations.	The Medication Adherence Rating Scale (MARS) is a 10-item self-report measure developed by Thompson, Kulkarni, and Sergejew in 2000 to assess medication adherence behaviors and attitudes in psychiatric populations, particularly antipsychotic medication use. Although originally validated in schizophrenia, it has been successfully applied across diverse medical conditions including hypertension, diabetes, and chronic disease management, providing a quick, sensitive assessment of actual adherence frequency and admission of problematic medication-taking behaviors.